Judith Bruchfeld Selected Research

HIV Infections (HIV Infection)

11/2014	Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
5/2002	Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Judith Bruchfeld Research Topics

Disease

14	Tuberculosis (Tuberculoses) 01/2021 - 11/2014
7	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 05/2010
6	Infections 04/2021 - 05/2011
4	Rheumatoid Arthritis 01/2021 - 11/2014
4	Extensively Drug-Resistant Tuberculosis 07/2020 - 02/2016
2	Reinfection 12/2021 - 07/2021
2	Pulmonary Tuberculosis 11/2021 - 01/2019
2	Latent Tuberculosis 01/2021 - 01/2019
2	HIV Infections (HIV Infection) 11/2014 - 05/2002
1	Coinfection 12/2021
1	Postural Orthostatic Tachycardia Syndrome 04/2021
1	Hemolysis 11/2020
1	Ankylosing Spondylitis 10/2018
1	Psoriatic Arthritis 10/2018
1	Necrosis 12/2015
1	Silicosis 12/2015
1	Immune Reconstitution Inflammatory Syndrome 02/2015
1	Latent Infection 11/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2014
1	Genomic Instability 01/2011

Drug/Important Bio-Agent (IBA)

17	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
4	FluoroquinolonesIBA 01/2020 - 02/2016
3	Biological ProductsIBA 01/2021 - 06/2015
3	lipoarabinomannan (LAM)IBA 01/2021 - 01/2015
3	Tuberculin (PPD)IBA 01/2020 - 01/2012
2	Pyrazinamide FDA LinkGeneric 11/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2019
2	AntigensIBA 01/2020 - 01/2012
2	InterferonsIBA 01/2020 - 11/2014
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2019 - 01/2018
2	bedaquiline (R207910)IBA 01/2019 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2019 - 01/2011
2	GoldIBA 11/2014 - 05/2011
2	Interferon-gamma (Interferon, gamma)IBA 01/2012 - 07/2011
1	Moxifloxacin (Avelox)FDA Link 01/2021
1	GlycolipidsIBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Prothionamide (Protionamide)IBA 11/2020
1	rifapentine (Priftin)FDA Link 01/2019
1	N 30IBA 01/2018
1	EnzymesIBA 11/2014
1	dimemorfan (AT 17)IBA 11/2014
1	Interleukin-12 (IL 12)IBA 01/2012
1	Interleukin-13IBA 01/2012
1	ChemokinesIBA 01/2012
1	Interleukin-17 (Interleukin 17)IBA 01/2012
1	CytokinesIBA 01/2012
1	Interleukin-2 (IL2)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	MitogensIBA 05/2011

Therapy/Procedure

2	Therapeutics 10/2018 - 06/2015
1	Ambulatory Care (Outpatient Care) 04/2021
1	Aftercare (After-Treatment) 01/2018
1	Transplantation 12/2015
1	Biological Therapy 06/2015
1	Art Therapy 02/2015
1	Stem Cell Transplantation 11/2014
1	Drug Therapy (Chemotherapy) 11/2014